Form D · Biotechnology

X-Vax Technology, Inc.

Jupiter, FL · CIK 0001682900

Offering snapshot reported Jul 18, 2019 · SEC filing

Reported sold
$56.5M
Offering amount: $58M
Investors reported
306
Form D · investor count
Minimum accepted
$20K
Reported outside-investor minimum
First sale
Sep 28, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$28.2M$56.5MOct 3, 2018: $6,550,000.00Oct 3, 2018Apr 15, 2019: $39,267,450.00Apr 15, 2019Apr 17, 2019: $42,187,450.00May 31, 2019: $46,682,455.00Jul 18, 2019: $56,463,455.00Jul 18, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$46,682,455 → $56,463,455
  • Reported investors269 → 306

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 18, 2019Amendment$56,463,455$9,781,000vs May 31, 2019306SEC filing
May 31, 2019Amendment$46,682,455$4,495,005vs Apr 17, 2019269SEC filing
Apr 17, 2019Amendment$42,187,450$35,637,450vs Oct 3, 2018242SEC filing
Apr 15, 2019Amendment$39,267,450$32,717,450vs Oct 3, 2018230SEC filing
Oct 3, 2018Initial$6,550,000No comparison9SEC filing
Sep 12, 2016Initial$100,000No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$5.65M
Finders' fees
$0
Form D file number
021-322669
The placement agent was paid a fee of $362,567.50 relating to the conversion of certain convertible notes that were converted into the offering.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Maxim Group LLC120708

Source: Form D, filed Jul 18, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Isaac Blech Director
Ian T. Clark Director
Andreas Eggert Executive
Brian D. Finn Director
William A. Haseltine Director
Roger A. Jeffs Director
Clare Kahn Executive
Richard Kenney Executive
Roger J. Pomerantz Director
Robert R. Ruffolo Director
Matthew R. Stober Director
Jacob Uittenbogaard Executive
Ulf Wiinberg Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
601 Heritage Drive, Suite 138
Jupiter, FL, 33458